The other EDRF

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.19, Iss.1, 1998-01, pp. : 37-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Excess EDRF/NO, a Potentially Deleterious Condition that may be Involved in Accelerated Atherogenesis and Other Chronic Disease States

By Defeudis F.V.

General Pharmacology, Vol. 26, Iss. 4, 1995-07 ,pp. : 667-680

Elsevier

Access to resources Recommend Favorite

Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes?

By Triggle Chris R Howarth Andrew Cheng Zhong J. Ding Hong

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 8-9, 2005-08 ,pp. : 681-700

NRC Research Press

Access to resources Recommend Favorite

Other Activities

Current Bioactive Compounds, Vol. 3, Iss. 2, 2007-06 ,pp. : 150-160

Bentham Science Publishers

Access to resources Recommend Favorite

Other Activities

Current Bioactive Compounds, Vol. 2, Iss. 4, 2006-12 ,pp. : 504-514

Bentham Science Publishers

Access to resources Recommend Favorite

Other Activities

Current Bioactive Compounds, Vol. 2, Iss. 3, 2006-09 ,pp. : 386-393

Bentham Science Publishers

Access to resources Recommend Favorite